The cholinergic anti-inflammatory pathway and the gastrointestinal tract.
Bonaz
Bruno
B
D000818:Animals; D000893:Anti-Inflammatory Agents / Q000494:pharmacology* / Q000627:therapeutic use / Q000633:toxicity; D001952:Bridged-Ring Compounds / Q000494:pharmacology* / Q000627:therapeutic use; D002490:Central Nervous System / Q000378:metabolism; D016207:Cytokines / Q000378:metabolism; D004195:Disease Models, Animal; D004599:Electric Stimulation Therapy; D005746:Gastric Emptying / Q000187:drug effects; D005759:Gastroenteritis / Q000378:metabolism / Q000503:physiopathology / Q000517:prevention & control*; D006801:Humans; D045823:Ileus / Q000378:metabolism / Q000503:physiopathology / Q000517:prevention & control*; D007422:Intestines / Q000187:drug effects* / Q000294:innervation / Q000503:physiopathology / Q000601:surgery; D017737:Macrophages, Peritoneal / Q000187:drug effects* / Q000378:metabolism; D016328:NF-kappa B / Q000378:metabolism; D009538:Nicotine / Q000494:pharmacology / Q000633:toxicity; D018722:Nicotinic Agonists / Q000494:pharmacology* / Q000627:therapeutic use / Q000633:toxicity; D011183:Postoperative Complications / Q000378:metabolism / Q000503:physiopathology / Q000517:prevention & control*; D011978:Receptors, Nicotinic / Q000187:drug effects / Q000378:metabolism; D012018:Reflex; D013141:Spiro Compounds / Q000494:pharmacology* / Q000627:therapeutic use; D014158:Transcription, Genetic / Q000187:drug effects; D014628:Vagotomy; D014630:Vagus Nerve / Q000601:surgery; D064569:alpha7 Nicotinic Acetylcholine Receptor
C408128:AR-R 17779; D000893:Anti-Inflammatory Agents; D001952:Bridged-Ring Compounds; C579167:Chrna7 protein, human; D016207:Cytokines; D016328:NF-kappa B; D018722:Nicotinic Agonists; D011978:Receptors, Nicotinic; D013141:Spiro Compounds; D064569:alpha7 Nicotinic Acetylcholine Receptor; D009538:Nicotine